MET and neoplasm: Given intratumor heterogeneity, direct morphological assessment of MET-overexpression and MET-GCNG/GA in tumor specimens using IHC and FISH is deemed to be more sensitive than NGS-based assessment of MET-amplification and more informative as to whether the deregulated MET-receptor signaling can be targeted in a specific patient [4].